Alaunos Therapeutics, Inc.

TCRT
$2.08 (- $0.08 - 3.70%)
Last updated: 2026-07-03 21:56 UTC
TCRT Metrics
Exchange
🇺🇸 NASDAQ XNCM
Nasdaq Capital MarketUnited StatesAmerica/New_York
SectorHealthcare
IndustryBiotechnology
ISINUS98973P1012
CUSIP98973P101
Market Price2.08
Dividend Yield N/A
Dividend Growth
1YN/A
3YN/A
5YN/A
10YN/A
Annual Dividend N/A
Latest Payout ($)N/A
Latest Payout DateN/A
Dividend FrequencyNone
P/E RatioN/A
EPS-2.3
Market Cap$7.9M
Book Value1.27
Price to Book2.769
Beta-1.29
52w High6.2
52w Low1.31
Next Earnings DateN/A

Alaunos Therapeutics, Inc. trades under ticker TCRT on NASDAQ as a stock. Use this page to review stock price, dividends, and price history. The page also shows Healthcare exposure. Identifiers: ISIN US98973P1012, CUSIP 98973P101.

About the Company
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops small molecules to treat obesity and other metabolic disorders. The company develops an oral obesity compound that addresses shortcomings of injectable GLP-1 receptor agonists, including preserving lean muscle mass. It also evaluates ALN1001 and related derivatives on lipid deposition and gene expression. In addition, the company develops hunTR TCR discovery platform to target driver mutations. Alaunos Therapeutics, Inc. was founded in 2003 and is headquartered in Houston, Texas.
Price History